Literature DB >> 16044381

Indirect MR arthrography: concepts and controversies.

William B Morrison1.   

Abstract

Indirect MR arthrography involves intravenous injection of a standard dose of Gadolinium contrast followed, in delayed fashion, by MR imaging. Contrast in taken up by the joint at a rate dependent on a variety of factors including synovial area, vascularity, permeability, and pre-existing joint effusion. Patient acceptance is higher than with direct intra-articular injection, and logical considerations (e.g., not needing a radiologist present) make this an attractive alternative to direct MR arthrography. At best, an indirect MR arthrography exam can look virtually identical to a direct MR arthrogram. However, the radiologist should be aware that vascular tissue inside and outside the joint will enhance, which may be considered either an advantage or disadvantage. Additionally, since all compartments of the joint enhance, information regarding abnormal communication of contrast material is absent. Suboptimal exams occur due to the need for diffusion of contrast into the joint. Exercise can help improve the quality of exams. Using an adequate time delay is essential for optimizing indirect MR arthrography.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16044381     DOI: 10.1055/s-2005-872338

Source DB:  PubMed          Journal:  Semin Musculoskelet Radiol        ISSN: 1089-7860            Impact factor:   1.777


  8 in total

1.  Morphological imaging and T2 and T2* mapping of hip cartilage at 7 Tesla MRI under the influence of intravenous gadolinium.

Authors:  Andrea Lazik-Palm; Oliver Kraff; Christina Geis; Sören Johst; Juliane Goebel; Mark E Ladd; Harald H Quick; Jens M Theysohn
Journal:  Eur Radiol       Date:  2016-02-12       Impact factor: 5.315

2.  Labral and cartilage abnormalities in young patients with hip pain: accuracy of 3-Tesla indirect MR arthrography.

Authors:  Catherine N Petchprapa; Leon D Rybak; Kevin S Dunham; Riccardo Lattanzi; Michael P Recht
Journal:  Skeletal Radiol       Date:  2014-10-03       Impact factor: 2.199

3.  Influence of field strength, coil type and image resolution on assessment of synovitis by unenhanced MRI--a comparison with contrast-enhanced MRI.

Authors:  Iris Eshed; Simon Krabbe; Mikkel Østergaard; Pernille Bøyesen; Jakob M Møller; Flemming Therkildsen; Ole Rintek Madsen; Mette Axelsen; Susanne Juhl Pedersen
Journal:  Eur Radiol       Date:  2014-12-24       Impact factor: 5.315

4.  Ferumoxytol magnetic resonance imaging detects joint and pleural infiltration of bone sarcomas in pediatric and young adult patients.

Authors:  Ashok J Theruvath; Ali Rashidi; Ramya R Nyalakonda; Raffi S Avedian; Robert J Steffner; Sheri L Spunt; Heike E Daldrup-Link
Journal:  Pediatr Radiol       Date:  2021-08-19

Review 5.  Advances in musculoskeletal MRI: technical considerations.

Authors:  Lauren Shapiro; Monica Harish; Brian Hargreaves; Ernesto Staroswiecki; Garry Gold
Journal:  J Magn Reson Imaging       Date:  2012-10       Impact factor: 4.813

Review 6.  Approach to MR Imaging of the Elbow and Wrist: Technical Aspects and Innovation.

Authors:  Dustin Johnson; Kathryn J Stevens; Geoffrey Riley; Lauren Shapiro; Hiroshi Yoshioka; Garry E Gold
Journal:  Magn Reson Imaging Clin N Am       Date:  2015-05-21       Impact factor: 2.266

7.  Indirect Magnetic Resonance Arthrography May Help Avoid Second Look Arthroscopy for Assessment of Healing After Bucket Handle Medial Meniscus Repairs: A Prospective Clinico-Radiological Observational Study.

Authors:  Sachin Tapasvi; Anshu Shekhar; Aparna Chandorkar; Anupama Patil; Shantanu Patil
Journal:  Indian J Orthop       Date:  2021-03-12       Impact factor: 1.251

Review 8.  Accuracy of magnetic resonance studies in the detection of chondral and labral lesions in femoroacetabular impingement: systematic review and meta-analysis.

Authors:  A M Saied; C Redant; M El-Batouty; M R El-Lakkany; W A El-Adl; J Anthonissen; R Verdonk; E A Audenaert
Journal:  BMC Musculoskelet Disord       Date:  2017-02-16       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.